Your browser doesn't support javascript.
loading
Reviewing the quality, health benefit and value for money of chemotherapy and targeted therapy for metastatic breast cancer.
Pouwels, Xavier Ghislain Léon Victor; Ramaekers, Bram L T; Joore, Manuela A.
Afiliação
  • Pouwels XGLV; Department of Clinical Epidemiology and Medical Technology Assessment (KEMTA), Care and Public Health Research Institute (CAPHRI) of the Faculty of Health, Medicine and Life Sciences of Maastricht University (FHML), Maastricht University Medical Centre, P.O. Box 5800, 6202 AZ, Maastricht, The Netherlands. xavier.pouwels@mumc.nl.
  • Ramaekers BLT; Department of Clinical Epidemiology and Medical Technology Assessment (KEMTA), Care and Public Health Research Institute (CAPHRI) of the Faculty of Health, Medicine and Life Sciences of Maastricht University (FHML), Maastricht University Medical Centre, P.O. Box 5800, 6202 AZ, Maastricht, The Netherlands.
  • Joore MA; Department of Clinical Epidemiology and Medical Technology Assessment (KEMTA), Care and Public Health Research Institute (CAPHRI) of the Faculty of Health, Medicine and Life Sciences of Maastricht University (FHML), Maastricht University Medical Centre, P.O. Box 5800, 6202 AZ, Maastricht, The Netherlands.
Breast Cancer Res Treat ; 165(3): 485-498, 2017 Oct.
Article em En | MEDLINE | ID: mdl-28689361

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Qualidade da Assistência à Saúde / Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Análise Custo-Benefício / Terapia de Alvo Molecular Tipo de estudo: Health_economic_evaluation / Prognostic_studies / Systematic_reviews Limite: Female / Humans Idioma: En Revista: Breast Cancer Res Treat Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Holanda

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Qualidade da Assistência à Saúde / Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Análise Custo-Benefício / Terapia de Alvo Molecular Tipo de estudo: Health_economic_evaluation / Prognostic_studies / Systematic_reviews Limite: Female / Humans Idioma: En Revista: Breast Cancer Res Treat Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Holanda